Renal and liver injury following the treatment of COVID-19 by remdesivir
Remdesivir initially was intravenously administrated to treat the Ebola disease however right now it has been administered to treat COVID-19 in some countries. However it is necessary to find the exact effect of remdesivir in patients with COVID-19. Remdesivir solution is administered with a cyclode...
Saved in:
Main Authors: | Mohsen Mohammad Rahimi (Author), Elham Jahantabi (Author), Behzad Lotfi (Author), Mehdi Forouzesh (Author), Rohollah Valizadeh (Author), Saman Farshid (Author) |
---|---|
Format: | Book |
Published: |
Society of Diabetic Nephropathy Prevention,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New hope for treatment of respiratory involvement following COVID-19 by bromhexine
by: Abdolrazagh Barzegar, et al.
Published: (2021) -
Drug therapy in hospitalized patients with very severe symptoms following COVID-19
by: Rohollah Valizadeh, et al.
Published: (2020) -
Remdesivir and the Liver: A Concise Narrative Review of Remdesivir-Associated Hepatotoxicity in Patients Hospitalized Due to COVID-19
by: Alireza FakhriRavari, et al.
Published: (2024) -
Effect of preoperative prostate volume on the improvement of lower urinary tract symptoms in patients with benign prostatic hyperplasia undergoing transurethral resection of prostate
by: Behzad Lotfi, et al.
Published: (2020) -
Appendix graft as a ureter substitution in recurrent ureter stenosis in horse -shoe kidney; a case report
by: Ali Taghizadeh Afshari, et al.
Published: (2018)